These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2094195)
1. [Reduction in glucose concentration in the brain of mice inoculated with cerebrospinal fluid from patients with amyotrophic lateral sclerosis]. Godoy JM; Skacel M; Lima JM; Andrade CM Arq Neuropsiquiatr; 1990 Dec; 48(4):473-7. PubMed ID: 2094195 [TBL] [Abstract][Full Text] [Related]
2. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis]. Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739 [TBL] [Abstract][Full Text] [Related]
10. [Immunological studies of the cerebrospinal fluid in patients with amyotrophic lateral sclerosis]. Chankov IA; Tsanev PS Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):29. PubMed ID: 1647620 [TBL] [Abstract][Full Text] [Related]
11. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056 [TBL] [Abstract][Full Text] [Related]
12. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473 [TBL] [Abstract][Full Text] [Related]
13. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Alonso R; Pisa D; Marina AI; Morato E; Rábano A; Rodal I; Carrasco L Int J Biol Sci; 2015; 11(5):546-58. PubMed ID: 25892962 [TBL] [Abstract][Full Text] [Related]
14. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Gomez-Pinedo U; Yáñez M; Matías-Guiu J; Galán L; Guerrero-Sola A; Benito-Martin MS; Vela A; Arranz-Tagarro JA; García AG Neurologia; 2014; 29(6):346-52. PubMed ID: 24144827 [TBL] [Abstract][Full Text] [Related]
15. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication. Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876 [TBL] [Abstract][Full Text] [Related]
16. Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis. Johansson A; Larsson A; Nygren I; Blennow K; Askmark H Neuroreport; 2003 Oct; 14(14):1867-9. PubMed ID: 14534437 [TBL] [Abstract][Full Text] [Related]
17. [Amyotrophic lateral sclerosis with important non-specific changes in the cerebrospinal fluid in a patient with diabetes of long standing]. LECHELLE P; THEVENARD A; DELAPORTE J Bull Mem Soc Med Hop Paris; 1952 Jul 4-11; 68(24-25):941-3. PubMed ID: 12988037 [No Abstract] [Full Text] [Related]
18. Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid. Krieger C; Perry TL; Ziltener HJ Can J Neurol Sci; 1992 Aug; 19(3):357-9. PubMed ID: 1393846 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis. de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112 [TBL] [Abstract][Full Text] [Related]